CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF)
CUSIP: G1933S101
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Ordinary Shares
- Shares outstanding
- 35,821,764
- Total 13F shares
- 344,608
- Share change
- -105,230
- Total reported value
- $882,628
- Price per share
- $2.56
- Number of holders
- 18
- Value change
- -$268,771
- Number of buys
- 5
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP G1933S101?
CUSIP G1933S101 identifies CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G1933S101:
Top shareholders of CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Wellington Shields Capital Management, LLC |
13F
|
Company |
0.5%
|
178,455
|
$446,138 | — | 30 Jun 2023 | |
| Wellington Shields & Co., LLC |
13F
|
Company |
0.24%
|
86,214
|
$215,535 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.23%
|
81,389
|
$203,472 | — | 30 Jun 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.08%
|
28,162
|
$70,405 | — | 30 Jun 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.07%
|
24,923
|
$62,058 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
22,221
|
$55,330 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
15,100
|
$38,000 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
10,318
|
$25,796 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,553
|
$3,883 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
661
|
$1,653 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
454
|
$1,135 | — | 30 Jun 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
204
|
$510 | — | 30 Jun 2023 | |
| WEST PACES ADVISORS INC. |
13F
|
Company |
0%
|
100
|
$250 | — | 30 Jun 2023 | |
| Fiduciary Alliance LLC |
13F
|
Company |
0%
|
30
|
$75 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
25
|
$62 | — | 30 Jun 2023 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
13
|
$33 | — | 30 Jun 2023 | |
| Colonial Trust Co / SC |
13F
|
Company |
0%
|
11
|
$28 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
5
|
$13 | — | 30 Jun 2023 |
Institutional Holders of CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) as of Q3 2023
As of 30 Sep 2023,
CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
344,608 shares.
The largest 10 holders included
Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, FRANKLIN RESOURCES INC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, Qube Research & Technologies Ltd, and Tower Research Capital LLC (TRC).
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
18
Q3 2023 holders
18
Holder diff
0
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.